Canada markets closed

Provectus Biopharmaceuticals, Inc. (PXY.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
0.04500.0000 (0.00%)
At close: 02:55PM CEST
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-2,778
-3,102
-3,555
-5,540
-6,678
Depreciation & amortization
8.922
8.921
10.895
12.865
241.79
Stock based compensation
-
2.85
3.025
23.688
134.754
Change in working capital
-271.435
472.922
446.408
4,472
2,142
Accounts Payable
-537.826
-418.37
807.073
331.148
-170.413
Other working capital
-2,992
-2,572
-3,041
-1,013
-4,086
Other non-cash items
45.656
45.097
52.883
81.258
73.579
Net cash provided by operating activites
-2,992
-2,572
-3,041
-1,013
-4,086
Cash flows from financing activities
Debt repayment
-386.053
-283.445
-259.659
-248.177
-105.985
Net cash used privided by (used for) financing activities
2,457
2,192
1,368
4,024
3,600
Net change in cash
-558.703
-404.908
-1,675
3,010
-493.475
Cash at beginning of period
1,321
1,432
3,107
97.231
590.706
Cash at end of period
786.039
1,027
1,432
3,107
97.231
Free Cash Flow
Operating Cash Flow
-2,992
-2,572
-3,041
-1,013
-4,086
Free Cash Flow
-2,992
-2,572
-3,041
-1,013
-4,086